SphingoTec

SphingoTec GmbH is a diagnostic company at the commercial stage, focusing on innovative critical care biomarkers for diagnosing, predicting, and monitoring acute medical conditions. SphingoTec's innovative markers are available on various IVD platforms. SphingoTec’s proprietary biomarker portfolio includes Proenkephalin A 119-159 (penKid), a biomarker used to assess kidney function in critically ill patients, and bioactive Adrenomedullin 1-52 (bio-ADM), a biomarker for evaluating endothelial function in conditions such as sepsis.